4.2 Article Proceedings Paper

Amyloid Imaging in Early Detection of Alzheimer's Disease

期刊

NEURODEGENERATIVE DISEASES
卷 7, 期 1-3, 页码 136-138

出版社

KARGER
DOI: 10.1159/000289223

关键词

Alzheimer's disease; Amyloid imaging; Positron emission tomography; Pittsburgh compound B; Mild cognitive impairment; Early diagnostic markers; CSF biomarkers

资金

  1. Swedish Research Council [05817]
  2. Stone's Foundation
  3. Alzheimer Foundation in Sweden
  4. Brain Foundation
  5. Foundation for Old Servants
  6. Foundation for Swedish Brain Power
  7. Knut and Alice Wallenberg Foundation
  8. EC [LSHB-CT-2005-512146, QLK6-CT-2000-00502]

向作者/读者索取更多资源

Amyloid imaging has provided evidence for early detection of amyloid (A beta) load in prodromal Alzheimer's disease (AD). Several amyloid tracers have been developed for studies with positron emission tomography (PET). Early detection of at-risk subjects will be important in the future for a successful treatment of AD. The high A beta load in the brain measured by PET in patients with mild cognitive impairment that later will convert to AD suggests early, significant, ongoing pathological processes prior to cognitive impairment. PET A beta imaging will also be used for discrimination of AD from other dementia disorders, as well for the evaluation of anti-A beta drugs. Copyright (C) 2010 S. Karger AG, Basel

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据